Molecular Analysis of Thoracic Malignancies
Trial ID or NCT#
NCT01385722
Status
NOT RECRUITING
Purpose
A ÌÇÐÄ´«Ã½ study to learn about the biologic features of cancer development, growth, and spread. We are studying components of blood, tumor tissue, normal tissue, and other fluids, such as urine, cerebrospinal fluid, abdominal or chest fluid in patients with cancer. Our analyses of blood, tissue, and/or fluids may lead to improved diagnosis and treatment of cancer by the identification of markers that predict clinical outcome, markers that predict response to specific therapies, and the identification of targets for new therapies.
Official Title
Molecular Analysis of Thoracic Malignancies
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Exclusion Criteria:
Investigator(s)
Stefanie S. Jeffrey, MD
Dean W. Felsher
Billy W Loo, Jr, MD PhD FASTRO FACR
Radiation oncologist,
Thoracic specialist
Professor of Radiation Oncology (Radiation Therapy)
Maximilian Diehn, MD, PhD
Radiation oncologist
Jack, Lulu, and Sam Willson Professor and Professor of Radiation Oncology (Radiation Therapy)
Rajat Rohatgi
Kavitha Ramchandran
Medical oncologist,
Palliative medicine doctor,
Thoracic specialist,
Internal medicine doctor
Clinical Professor, Medicine - Oncology
Melanie Hayden Gephart
Neurosurgeon
Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences
Seema Nagpal, MD
Neuro-oncologist
Clinical Professor, Adult Neurology
Clinical Professor (By courtesy), Neurosurgery
Contact us to find out if this trial is right for you.
Contact
Jordan Preiss
650-723-1002
View on